ArticleScientific reports2026
Computational identification and mechanistic characterization of natural product binders targeting the PDE6D prenyl binding tunnel.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structural Remodeling of TCR-HLA-DQ8 Recognition by a β-Cell Stress-Associated C19S Insulin Neoepitope in Type 1 Diabetes.International journal of molecular sciences · 2026Article
- GC-MS metabolomic profiling and PPARγ-targetedFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RAS oncogenesis remains a significant clinical challenge due to the difficulty of directly targeting RAS proteins. PDE6D, a prenyl-binding chaperone involved in the RAS membrane trafficking pathway, represents an indirect yet tractable target whose modulation has been proposed to influence RAS localization and signaling. This study employed a multiscale structure-based in silico workflow to identify natural compounds with putative binding potential toward the prenyl-binding tunnel of PDE6D. A curated natural product library was screened using molecular docking, followed by density functional theory–based geometry optimization. Additional 500 ns molecular dynamics simulations were then used to analyze the stability of binding and the overall conformational behavior of the most promising complexes. Further PCA and free energy landscape mapping highlighted distinct low-energy conformational states adopting unique structural transitions, where the MolPort-039-052-621 complex presented the most compact and well-defined low-energy basin. In that respect, superimposing free energy minima with the respective initial docked poses demonstrated minimal structural deviation from the binding orientation during dynamic evolution. Finally, QM/MM calculations qualitatively described the electronic stabilization of the ligands within the PDE6D environment. The present study identifies natural compounds with computationally favourable tunnel-binding characteristics and provides mechanistic insights that may guide future experimental validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.